Published in Lancet on March 20, 2004
Unhealthy landscapes: Policy recommendations on land use change and infectious disease emergence. Environ Health Perspect (2004) 3.47
Prediction and prevention of the next pandemic zoonosis. Lancet (2012) 3.44
Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev (2008) 3.07
Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg Infect Dis (2005) 2.93
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A (2005) 2.86
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic. Antiviral Res (2009) 2.03
Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog (2008) 1.92
Primate-to-human retroviral transmission in Asia. Emerg Infect Dis (2005) 1.87
Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors. J Virol (2005) 1.84
Human health impacts of ecosystem alteration. Proc Natl Acad Sci U S A (2013) 1.80
Human viruses: discovery and emergence. Philos Trans R Soc Lond B Biol Sci (2012) 1.66
Restriction of foamy viruses by APOBEC cytidine deaminases. J Virol (2006) 1.52
Temple monkeys and health implications of commensalism, Kathmandu, Nepal. Emerg Infect Dis (2006) 1.46
Frequent and recent human acquisition of simian foamy viruses through apes' bites in central Africa. PLoS Pathog (2011) 1.39
Simian foamy virus transmission from apes to humans, rural Cameroon. Emerg Infect Dis (2007) 1.35
Exposure to nonhuman primates in rural Cameroon. Emerg Infect Dis (2004) 1.35
Sensitive assays for simian foamy viruses reveal a high prevalence of infection in commensal, free-ranging Asian monkeys. J Virol (2007) 1.30
Zoonotic viruses associated with illegally imported wildlife products. PLoS One (2012) 1.29
Coinfection of Ugandan red colobus (Procolobus [Piliocolobus] rufomitratus tephrosceles) with novel, divergent delta-, lenti-, and spumaretroviruses. J Virol (2009) 1.27
Diverse contexts of zoonotic transmission of simian foamy viruses in Asia. Emerg Infect Dis (2008) 1.27
Interspecies transmission of simian foamy virus in a natural predator-prey system. J Virol (2008) 1.25
An endogenous foamy-like viral element in the coelacanth genome. PLoS Pathog (2012) 1.24
Expanded tissue targets for foamy virus replication with simian immunodeficiency virus-induced immunosuppression. J Virol (2006) 1.23
Extensive survey on the prevalence and genetic diversity of SIVs in primate bushmeat provides insights into risks for potential new cross-species transmissions. Infect Genet Evol (2009) 1.20
Feline lentivirus evolution in cross-species infection reveals extensive G-to-A mutation and selection on key residues in the viral polymerase. J Virol (2006) 1.20
No association of xenotropic murine leukemia virus-related viruses with prostate cancer. PLoS One (2011) 1.19
Modes of transmission and genetic diversity of foamy viruses in a Macaca tonkeana colony. Retrovirology (2006) 1.14
Beyond bushmeat: animal contact, injury, and zoonotic disease risk in Western Uganda. Ecohealth (2014) 1.13
Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet. J Biol Chem (2008) 1.12
Replication in a superficial epithelial cell niche explains the lack of pathogenicity of primate foamy virus infections. J Virol (2008) 1.08
High prevalence, coinfection rate, and genetic diversity of retroviruses in wild red colobus monkeys (Piliocolobus badius badius) in Tai National Park, Cote d'Ivoire. J Virol (2010) 1.08
Heparan sulfate is an attachment factor for foamy virus entry. J Virol (2012) 1.07
Simian T-lymphotropic virus diversity among nonhuman primates, Cameroon. Emerg Infect Dis (2009) 1.03
Novel simian foamy virus infections from multiple monkey species in women from the Democratic Republic of Congo. Retrovirology (2012) 1.03
High GUD incidence in the early 20 century created a particularly permissive time window for the origin and initial spread of epidemic HIV strains. PLoS One (2010) 1.03
Centrosomal latency of incoming foamy viruses in resting cells. PLoS Pathog (2007) 1.02
Novel multiplexed HIV/simian immunodeficiency virus antibody detection assay. Emerg Infect Dis (2011) 1.02
The origin and prevention of pandemics. Clin Infect Dis (2010) 1.02
Animal virus discovery: improving animal health, understanding zoonoses, and opportunities for vaccine development. Curr Opin Virol (2012) 1.01
Influence of naturally occurring simian foamy viruses (SFVs) on SIV disease progression in the rhesus macaque (Macaca mulatta) model. Viruses (2013) 1.01
Identification of novel, highly expressed retroviral microRNAs in cells infected by bovine foamy virus. J Virol (2014) 1.00
New Streptococcus pneumoniae clones in deceased wild chimpanzees. J Bacteriol (2007) 0.99
Cross-species transmission of simian foamy virus to humans in rural Gabon, Central Africa. J Virol (2011) 0.98
Analysis of patterns of bushmeat consumption reveals extensive exploitation of protected species in eastern Madagascar. PLoS One (2011) 0.96
Simian retroviral infections in human beings. Lancet (2004) 0.96
HIV Genetic Diversity and Drug Resistance. Viruses (2010) 0.96
Host genes important to HIV replication and evolution. Cold Spring Harb Perspect Med (2012) 0.95
Viral host jumps: moving toward a predictive framework. Ecohealth (2008) 0.94
Restrictions to cross-species transmission of lentiviral infection gleaned from studies of FIV. Vet Immunol Immunopathol (2009) 0.93
Noncanonical microRNA (miRNA) biogenesis gives rise to retroviral mimics of lymphoproliferative and immunosuppressive host miRNAs. MBio (2014) 0.92
Origin and diversity of human retroviruses. AIDS Rev (2014) 0.92
Discovery of prosimian and afrotherian foamy viruses and potential cross species transmissions amidst stable and ancient mammalian co-evolution. Retrovirology (2014) 0.91
Viral latency in blood and saliva of simian foamy virus-infected humans. PLoS One (2013) 0.91
The phylogeography of orangutan foamy viruses supports the theory of ancient repopulation of Sumatra. J Virol (2004) 0.90
Reservoir host immune responses to emerging zoonotic viruses. Cell (2014) 0.90
Two distinct variants of simian foamy virus in naturally infected mandrills (Mandrillus sphinx) and cross-species transmission to humans. Retrovirology (2010) 0.89
A gorilla reservoir for human T-lymphotropic virus type 4. Emerg Microbes Infect (2014) 0.87
Using human disease outbreaks as a guide to multilevel ecosystem interventions. Environ Health Perspect (2004) 0.87
Model or meal? Farm animal populations as models for infectious diseases of humans. Nat Rev Microbiol (2009) 0.87
Innate sensing of foamy viruses by human hematopoietic cells. J Virol (2011) 0.87
Evidence for selection at HIV host susceptibility genes in a West Central African human population. BMC Evol Biol (2012) 0.87
Non-simian foamy viruses: molecular virology, tropism and prevalence and zoonotic/interspecies transmission. Viruses (2013) 0.87
Spillover and pandemic properties of zoonotic viruses with high host plasticity. Sci Rep (2015) 0.87
Genetic characterization of simian foamy viruses infecting humans. J Virol (2012) 0.86
Genetic characterization of the complete genome of a highly divergent simian T-lymphotropic virus (STLV) type 3 from a wild Cercopithecus mona monkey. Retrovirology (2009) 0.85
Drivers of bushmeat hunting and perceptions of zoonoses in Nigerian hunting communities. PLoS Negl Trop Dis (2015) 0.84
Zoonotic disease risk and the bushmeat trade: assessing awareness among hunters and traders in Sierra Leone. Ecohealth (2013) 0.84
Similar patterns of infection with bovine foamy virus in experimentally inoculated calves and sheep. J Virol (2013) 0.83
Contact to Non-human Primates and Risk Factors for Zoonotic Disease Emergence in the Taï Region, Côte d'Ivoire. Ecohealth (2015) 0.83
Enhanced heterosexual transmission hypothesis for the origin of pandemic HIV-1. Viruses (2012) 0.82
A rare null allele potentially encoding a dominant-negative TRIM5alpha protein in Baka pygmies. Virology (2009) 0.82
Public Health Risks from Illegally Imported African Bushmeat and Smoked Fish : Public Health Risks from African Bushmeat and Smoked Fish. Ecohealth (2015) 0.81
Molecular epidemiology of endemic human T-lymphotropic virus type 1 in a rural community in Guinea-Bissau. PLoS Negl Trop Dis (2012) 0.80
Detection of transmission clusters of HIV-1 subtype C over a 21-year period in Cape Town, South Africa. PLoS One (2014) 0.80
Uncovering zoonoses awareness in an emerging disease 'hotspot'. Soc Sci Med (2014) 0.80
Primates and primatologists: social contexts for interspecies pathogen transmission. Am J Primatol (2011) 0.80
Wide distribution and ancient evolutionary history of simian foamy viruses in New World primates. Retrovirology (2015) 0.80
Simian foamy virus in non-human primates and cross-species transmission to humans in Gabon: an emerging zoonotic disease in central Africa? Viruses (2013) 0.80
Could FIV zoonosis responsible of the breakdown of the pathocenosis which has reduced the European CCR5-Delta32 allele frequencies? Virol J (2008) 0.79
Cross-species transmissions of simian retroviruses in Africa and risk for human health. Lancet (2004) 0.79
Simian retroviral infections in human beings. Lancet (2004) 0.79
The ecology of primate retroviruses - an assessment of 12 years of retroviral studies in the Taï national park area, Côte d׳Ivoire. Virology (2014) 0.79
Dual Simian Foamy Virus/Human Immunodeficiency Virus Type 1 Infections in Persons from Côte d'Ivoire. PLoS One (2016) 0.78
Emerging disease: Looking for trouble. Nature (2009) 0.78
Horizontal acquisition and a broad biodistribution typify simian foamy virus infection in a cohort of Macaca fascicularis. Virol J (2013) 0.78
Mucosal and systemic antibody responses in humans infected with simian foamy virus. J Virol (2005) 0.78
Exposure to wild primates among HIV-infected persons. Emerg Infect Dis (2007) 0.77
Cocirculation of Two env Molecular Variants, of Possible Recombinant Origin, in Gorilla and Chimpanzee Simian Foamy Virus Strains from Central Africa. J Virol (2015) 0.77
Molecular cloning and anti-HIV-1 activities of APOBEC3s from northern pig-tailed macaques (Macaca leonina). Dongwuxue Yanjiu (2016) 0.77
Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa. Emerg Health Threats J (2010) 0.77
On the general theory of the origins of retroviruses. Theor Biol Med Model (2010) 0.75
The need to include animal protection in public health policies. J Public Health Policy (2013) 0.75
A seroprevalence study of primate workers for asymptomatic rhesus cytomegalovirus infection. J Clin Virol (2014) 0.75
Integrated biological-behavioural surveillance in pandemic-threat warning systems. Bull World Health Organ (2016) 0.75
High Prevalences and a Wide Genetic Diversity of Simian Retroviruses in Non-human Primate Bushmeat in Rural Areas of the Democratic Republic of Congo. Ecohealth (2017) 0.75
Failure to detect simian immunodeficiency virus infection in a large Cameroonian cohort with high non-human primate exposure. Ecohealth (2012) 0.75
Bushmeat Hunting and Zoonotic Transmission of Simian T-Lymphotropic Virus 1 in Tropical West and Central Africa. J Virol (2017) 0.75
Zoonotic infection of Brazilian primate workers with New World simian foamy virus. PLoS One (2017) 0.75
A Review of Zoonotic Infection Risks Associated with the Wild Meat Trade in Malaysia. Ecohealth (2017) 0.75
Designing graduate training programs in conservation medicine-producing the right professionals with the right tools. Ecohealth (2009) 0.75
Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92
Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med (2009) 28.62
Strategies for mitigating an influenza pandemic. Nature (2006) 25.20
Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update. PLoS One (2009) 8.37
Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27
Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. PLoS Med (2008) 7.46
Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. J Virol (2009) 5.91
Intermittent prophylaxis with oral truvada protects macaques from rectal SHIV infection. Sci Transl Med (2010) 5.85
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges. J Infect Dis (2006) 5.24
Travelling waves in the occurrence of dengue haemorrhagic fever in Thailand. Nature (2004) 5.05
Serotype-specific dengue virus circulation and dengue disease in Bangkok, Thailand from 1973 to 1999. Am J Trop Med Hyg (2003) 4.75
Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine. J Virol (2009) 4.73
DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J Exp Med (2003) 4.69
A panel of MHC class I restricted viral peptides for use as a quality control for vaccine trial ELISPOT assays. J Immunol Methods (2002) 4.48
Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev (2008) 4.46
Origin of the human malaria parasite Plasmodium falciparum in gorillas. Nature (2010) 4.35
Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy. PLoS Med (2008) 4.12
Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated. J Infect Dis (2005) 3.91
The challenge of HIV-1 subtype diversity. N Engl J Med (2008) 3.88
The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region. Am J Clin Pathol (2010) 3.83
Absence of evidence of xenotropic murine leukemia virus-related virus infection in persons with chronic fatigue syndrome and healthy controls in the United States. Retrovirology (2010) 3.64
Historical perspective--Emergence of influenza A (H1N1) viruses. N Engl J Med (2009) 3.53
The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling. PLoS Med (2009) 3.26
Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis (2002) 2.98
Bushmeat hunting, deforestation, and prediction of zoonoses emergence. Emerg Infect Dis (2005) 2.93
Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A (2005) 2.86
Association of herpes simplex virus type 2 infection and syphilis with human immunodeficiency virus infection among men who have sex with men in Peru. J Infect Dis (2006) 2.83
The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities. J Infect Dis (2004) 2.76
Ancient co-speciation of simian foamy viruses and primates. Nature (2005) 2.71
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med (2011) 2.71
Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe (2012) 2.66
Prevalence of transmitted drug resistance associated mutations and HIV-1 subtypes in new HIV-1 diagnoses, U.S.-2006. AIDS (2010) 2.62
African great apes are natural hosts of multiple related malaria species, including Plasmodium falciparum. Proc Natl Acad Sci U S A (2010) 2.60
Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis. Infect Control Hosp Epidemiol (2013) 2.59
Simulating school closure strategies to mitigate an influenza epidemic. J Public Health Manag Pract (2010) 2.59
Global health is public health. Lancet (2010) 2.59
Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis. Lancet Infect Dis (2013) 2.51
Policy rebuttal. HIV vaccine trial justified. Science (2004) 2.49
Susceptibility of HIV-2, SIV and SHIV to various anti-HIV-1 compounds: implications for treatment and postexposure prophylaxis. Antivir Ther (2004) 2.45
Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol (2004) 2.44
Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination. Virology (2008) 2.37
Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial. PLoS One (2011) 2.36
Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis. MMWR Recomm Rep (2005) 2.35
Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis (2004) 2.29
Containing a large bioterrorist smallpox attack: a computer simulation approach. Int J Infect Dis (2006) 2.29
HIV, transmitted drug resistance, and the paradox of preexposure prophylaxis. Proc Natl Acad Sci U S A (2010) 2.25
A computer simulation of employee vaccination to mitigate an influenza epidemic. Am J Prev Med (2009) 2.20
Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity. Proc Natl Acad Sci U S A (2003) 2.20
Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PLoS One (2010) 2.16
A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. Vaccine (2010) 2.13
The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions. J Virol (2006) 2.10
Simple PCR assays improve the sensitivity of HIV-1 subtype B drug resistance testing and allow linking of resistance mutations. PLoS One (2007) 2.09
Policies to reduce influenza in the workplace: impact assessments using an agent-based model. Am J Public Health (2013) 2.06
Dynamic effects of antibody-dependent enhancement on the fitness of viruses. Proc Natl Acad Sci U S A (2005) 2.02
Genetic diversity and phylogeographic clustering of SIVcpzPtt in wild chimpanzees in Cameroon. Virology (2007) 2.01
Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg Infect Dis (2006) 1.99
Forty-one near full-length HIV-1 sequences from Kenya reveal an epidemic of subtype A and A-containing recombinants. AIDS (2002) 1.98
Serologic evidence for exposure to simian virus 40 in North American zoo workers. J Infect Dis (2004) 1.98
Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya. PLoS One (2008) 1.97
Dicer is required for chromosome segregation and gene silencing in fission yeast cells. Proc Natl Acad Sci U S A (2002) 1.97
Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS (2002) 1.96
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX B/E prime-boost HIV-1 vaccine trial in Thailand. Vaccine (2005) 1.96
Adoptive transfer of costimulated CD4+ T cells induces expansion of peripheral T cells and decreased CCR5 expression in HIV infection. Nat Med (2002) 1.93
IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells. Proc Natl Acad Sci U S A (2004) 1.92
Molecular ecology and natural history of simian foamy virus infection in wild-living chimpanzees. PLoS Pathog (2008) 1.92
Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models. Virology (2008) 1.89
Reduction in the incidence of influenza A but not influenza B associated with use of hand sanitizer and cough hygiene in schools: a randomized controlled trial. Pediatr Infect Dis J (2011) 1.87
Seroprevalence and distribution of Flaviviridae, Togaviridae, and Bunyaviridae arboviral infections in rural Cameroonian adults. Am J Trop Med Hyg (2006) 1.87
Single versus multi-dose vaccine vials: an economic computational model. Vaccine (2010) 1.84
Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing. J Clin Microbiol (2006) 1.83
Prevalences, genotypes, and risk factors for HIV transmission in South America. J Acquir Immune Defic Syndr (2005) 1.82